Wealth Enhancement Advisory Services
TNXP icon

Wealth Enhancement Advisory Services’s Tonix Pharmaceuticals TNXP Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
+23,679
New +$306K ﹤0.01% 3216

Other funds holding TNXP

TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

Wealth Enhancement Advisory Services's TNXP Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 23,679 shares worth $297K. The stake represents ﹤0.01% of the portfolio and ranks #3216 among its holdings.

6 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Wealth Enhancement Advisory Services held 23,679 shares of Tonix Pharmaceuticals worth $297K as of Q2 2026.
  • Tonix Pharmaceuticals was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3216 holding.
  • 6 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.